176
143.
Cordina L.R. Chronic cyanosis and vascular function: implications for
patients with cyanotic congenital heart disease / L.R. Cordina, D.S.Celermajer
// Cardiol. Young. – 2010. – Apr; V 26. – P. 1-12.
144.
Descriptive Epidemiology of Congenital Heart Diseases in Northern
England: A 19 Year Register-Based Study / P. Dadvand et al. // Paediatric &
Perinatal Epidemiology. – 2008. – Vol 23. – P. 58-65.
145.
Down syndrome and abberante right subclavian artery / M.T.R. Roofthooft
et al. // European journal of pediatrics. – 2008. – V. 167 (9). – P. 1033-1036.
146.
Ebels T. What is the preferred therapy for patients with aortic coarctation –
The standard gamble and decision analysis versus real results? / T. Ebels, B.
Maruszewski, E.H. Blackstone // Cardiology in the young. – 2008. – V. 18 (4).
– P. 448.
147.
Ebstein
,
s anomaly: factors, associated with death in childhood and
adolescence: a multi-centre, long-term study / L. Kapusta et al. // European
heart journal. – 2007. – V. 28 (1). – P. 2661-2666.
148.
Effect of prenatal diagnosis on outcomes in D-transposition of the great
arteries / L.M. Bartlett et al. // Pediatrics. – 2004. – V. 113, № 4. – Р. 335-340.
149.
Epidemiologic features of the presentation of critical congenital heart
disease: implication for screening / A.H. Schultz et al. // Pediatrics. – 2008. –
V. 121, № 4. – Р. 751-757.
150.
Gender and outcome in adult congenital heart disease / C.L. Verheugt et
al. // Circulation. – 2008. – V. 118 (1). – P. 26-32.
151.
Gestational and family risk factors for carriers of congenital heart defects
in southern Brazil / Zen T.D. et al. // Pediatrics International – 2011. – Feb 22.
V. 10. – P. 1111
152.
Heron M. Deaths: leading causes for 2005 / M. Heron, B. Tejada-Vera //
Natl. Vital. Stat. Rep. – 2009. – Dec 23; V. 58(8). – P. 3-9.
